U.S. Pharma Stock News

Millicom International Cellular S.A. has convened its May 20, 2026 AGM in Luxembourg, where shareholders previously approved the 2025 accounts and a proposed US$3.00 per share dividend to be paid in four equal installments between July 2026 and April 2027, alongside a new share repurchase plan. By pairing a multi‑installment dividend with authorization for buybacks, Millicom is signaling a clear emphasis on flexible capital returns and balance sheet management. We’ll now examine how the...

FedEx (FDX) has just paired a firm third quarter earnings update with a higher full year revenue outlook and the launch of FedEx SameDay Local, a new fast delivery option built around tighter delivery windows. See our latest analysis for FedEx. The recent Q3 beat, raised full year revenue outlook, and SameDay Local launch come after a strong run, with a 19.25% year to date share price return and a 46.49% total shareholder return over the past year suggesting momentum has been building despite...

Johnson & Johnson (JNJ) is back in the spotlight after recent regulatory and clinical milestones, including US approval of ICOTYDE for moderate to severe plaque psoriasis and encouraging early data from an intravesical bladder cancer therapy. See our latest analysis for Johnson & Johnson. Despite a steady stream of clinical and regulatory updates, Johnson & Johnson’s share price has had a mixed few months, with a 30 day share price return showing a 2.86% decline, a 90 day share price return...

AllianceBernstein Holding (AB) has been drawing attention after recent trading left the units around $37, with total return over the past year at 4.8% and multi year returns reflecting a longer track record. See our latest analysis for AllianceBernstein Holding. Recent trading has been a bit softer, with a 30 day share price return of a 3.9% decline and a 90 day share price return of a 5.5% decline. However, the 1 year total shareholder return of 4.8% and 3 year total shareholder return of...

Cintas, ticker NasdaqGS:CTAS, has agreed to acquire UniFirst in a cash and stock transaction. The deal is set to combine two major players in uniforms and facility services, pending customary approvals. The transaction is designed to expand Cintas reach across customers, service routes, and product offerings. Cintas comes into this planned acquisition with shares at $168.85 and a record of returns over multi year periods. The stock is down 7.1% over the past week, 15.0% over the past month,...

Agilent Technologies, Inc. ( NYSE:A ) is about to trade ex-dividend in the next three days. The ex-dividend date is...

LGI Homes has opened Goldfields Ranch in Linda, California, a 499-homesite community featuring three- to five-bedroom single-family homes with its CompleteHome Plus upgrade package included in the price, plus a planned 4.25-acre park and quick access to CA-70 and nearby shopping and recreation. This large-scale Sacramento–Yuba City area community, with move-in-ready homes starting in the US$450,000s and extensive onsite amenities, underscores LGI Homes’ continued push into entry-level and...

Recent share performance and business scale Recent trading in Intuitive Surgical (ISRG) has drawn attention after a one-month return of about a 5% decline and a past three-month return of about a 19% decline, against a market value near US$166.9b. The company generates about US$10.1b in annual revenue and US$2.9b in net income, primarily from its Surgical & Medical Equipment operations. This provides investors with a sizeable, established player in minimally invasive care to evaluate. See our...

TestMu AI has announced the integration of a robust browser infrastructure to its Browser Cloud, specifically designed to enhance the scalability and reliability of AI agents. This development addresses a significant infrastructure bottleneck, allowing AI agents to interact effectively with the web at an enterprise scale. By providing a high-performance, scalable test cloud, TestMu AI enhances the capabilities of AI agents to handle agent-scale workloads with greater efficiency. This...

What the latest earnings mean for Mondelez International (MDLZ) Mondelez International (MDLZ) recently reported quarterly results in which revenue topped analyst expectations, but higher cocoa costs weighed on profitability, and the stock has slipped since, reflecting investor focus on margin pressure. See our latest analysis for Mondelez International. At a share price of $57.58, Mondelez shows a 7.33% year to date share price return, while the 1 year total shareholder return of a 12.0%...

Why Saia’s Recent Trading Performance Is Drawing Attention Saia (SAIA) has seen mixed share performance recently, with a roughly 2.2% decline over the last day, a 4.9% gain in the past week, and a month pullback of about 16.1%. See our latest analysis for Saia. At a share price of US$336.78, Saia’s recent moves show fading short term momentum. The stock has seen a 16.1% decline in its 30 day share price return, set against a 1 year total shareholder return decline of 10.43%, but positive 3...

Wondering if Camtek at around US$159.86 is still offering value after such a strong run, or if you might be looking at a stock that has already priced in much of the good news. The share price shows a mixed picture in the short term, with a 7.2% decline over the last week and a 2.4% decline over the past month, while still sitting on a 38.4% year to date gain and a 153.9% return over the past year. Those moves come alongside a very large 3 year return of roughly 5x and a 393.3% return over 5...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Franklin...

The upcoming earnings release for Arista Networks (ANET) is in focus, with consensus forecasts pointing to EPS of $0.81 and revenue growth of 30.13% year over year, reflecting expectations for stronger financial performance. See our latest analysis for Arista Networks. Despite a 9.23% 1-day and 10.06% 7-day share price decline to US$122.55, Arista Networks still carries a 55.21% 1-year total shareholder return and a very large 5-year total shareholder return, so recent weakness contrasts with...

If you are wondering whether Novo Nordisk’s current share price offers value or carries more risk than reward, it starts with understanding how the market is now treating this long established pharmaceutical name. The stock last closed at US$36.40, with returns of a 1.8% decline over 7 days, 5.7% decline over 30 days, 30.5% decline year to date, 47.1% decline over 1 year, and 52.5% decline over 3 years, while the 5 year return sits at 13.2%. These moves have come as attention around Novo...

Index removal puts Masco in focus Masco (MAS) was recently removed from the FTSE All-World Index (USD). This type of event can prompt mechanical selling by index-tracking funds and bring short term trading pressures onto the stock. See our latest analysis for Masco. At a share price of US$60.19, Masco has had a 1 month share price return of 18.53% decline and a 1 year total shareholder return of 12.96% decline. However, the 3 year total shareholder return of 31.17% suggests longer term...

Lockheed Martin (NYSE:LMT) is part of a consortium selected by the Pentagon to provide software for the new "Golden Dome" missile defense integration program, valued at about US$185b. The company is working alongside defense software and AI players, including Palantir and Anduril, within this multi decade effort to unify missile defense systems. Terran Orbital, in which Lockheed Martin has a key role, is expanding its space and defense electronics offering with a new star tracker product...

ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and reiterated its focus on regulatory compliance. This exchange centers on claims about ADMA Biologics' business practices and disclosures. For investors, this is notable because ADMA Biologics operates in a tightly regulated biopharmaceutical space where compliance is central to its plasma based therapies business. When a short-seller...

BancFirst Corporation ( NASDAQ:BANF ) is about to trade ex-dividend in the next three days. The ex-dividend date is one...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Earnings results and 2026 outlook draw fresh focus to GDS Holdings GDS Holdings (GDS) is back in the spotlight after reporting fourth quarter and full year 2025 results that combined higher revenue with sharply weaker profitability, along with 2026 revenue guidance pointing to further top line expansion. See our latest analysis for GDS Holdings. The share price reaction to the latest earnings and 2026 guidance has been negative in the short term, with a 1 day share price return of a 6.69%...

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...